HDAC Up-Regulation in Early Colon Field Carcinogenesis Is Involved in Cell Tumorigenicity through Regulation of Chromatin Structure

Normal cell function is dependent on the proper maintenance of chromatin structure. Regulation of chromatin structure is controlled by histone modifications that directly influence chromatin architecture and genome function. Specifically, the histone deacetylase (HDAC) family of proteins modulate chromatin compaction and are commonly dysregulated in many tumors, including colorectal cancer (CRC). However, the role of HDAC proteins in early colorectal carcinogenesis has not been previously reported. We found HDAC1, HDAC2, HDAC3, HDAC5, and HDAC7 all to be up-regulated in the field of human CRC. Furthermore, we observed that HDAC2 up-regulation is one of the earliest events in CRC carcinogenesis and observed this in human field carcinogenesis, the azoxymethane-treated rat model, and in more aggressive colon cancer cell lines. The universality of HDAC2 up-regulation suggests that HDAC2 up-regulation is a novel and important early event in CRC, which may serve as a biomarker. HDAC inhibitors (HDACIs) interfere with tumorigenic HDAC activity; however, the precise mechanisms involved in this process remain to be elucidated. We confirmed that HDAC inhibition by valproic acid (VPA) targeted the more aggressive cell line. Using nuclease digestion assays and transmission electron microscopy imaging, we observed that VPA treatment induced greater changes in chromatin structure in the more aggressive cell line. Furthermore, we used the novel imaging technique partial wave spectroscopy (PWS) to quantify nanoscale alterations in chromatin. We noted that the PWS results are consistent with the biological assays, indicating a greater effect of VPA treatment in the more aggressive cell type. Together, these results demonstrate the importance of HDAC activity in early carcinogenic events and the unique role of higher-order chromatin structure in determining cell tumorigenicity.

[1]  K. Zaret,et al.  Micrococcal Nuclease Analysis of Chromatin Structure , 2005, Current protocols in molecular biology.

[2]  Robert E. Brown,et al.  Field effect in cancer-an update. , 2009, Annals of clinical and laboratory science.

[3]  William M. Grady,et al.  Epigenetics and colorectal cancer , 2011, Nature Reviews Gastroenterology &Hepatology.

[4]  K. Chin,et al.  Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression , 2009, Clinical Cancer Research.

[5]  E. Liu,et al.  Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Marks,et al.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Pazin,et al.  Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions , 2006, Science.

[8]  Allen Taflove,et al.  Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells , 2008, Proceedings of the National Academy of Sciences.

[9]  Vadim Backman,et al.  Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. , 2010, Biophysical journal.

[10]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[11]  Manel Esteller,et al.  The role of histone deacetylases (HDACs) in human cancer , 2007, Molecular oncology.

[12]  Vadim Backman,et al.  Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. , 2009, Cancer research.

[13]  T. Heinzel,et al.  Histone deacetylase as a therapeutic target , 2001, Trends in Endocrinology & Metabolism.

[14]  Edward L. Lee,et al.  Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma , 2009, Digestive Diseases and Sciences.

[15]  M. Ferrari,et al.  What does physics have to do with cancer? , 2011, Nature Reviews Cancer.

[16]  H. G. Davies,et al.  The Use of the Interference Microscope to Determine Dry Mass in Living Cells and as a Quantitative Cytochemical Method , 1954 .

[17]  Ping Zhu,et al.  Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. , 2004, Cancer cell.

[18]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[19]  R. Barer,et al.  Refractive Index of Concentrated Protein Solutions , 1954, Nature.

[20]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[21]  V. Richon,et al.  Histone deacetylase inhibitors as new cancer drugs , 2001, Current opinion in oncology.

[22]  H. Roy,et al.  Down‐regulation of the tumor suppressor gene C‐terminal Src kinase: An early event during premalignant colonic epithelial hyperproliferation , 2005, FEBS letters.

[23]  H. Roy,et al.  Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase , 2008, Molecular Cancer Therapeutics.

[24]  James Ranger-Moore,et al.  Karyometry of the Colonic Mucosa , 2007, Cancer Epidemiology Biomarkers & Prevention.

[25]  Tom Misteli,et al.  Higher-order genome organization in human disease. , 2010, Cold Spring Harbor perspectives in biology.

[26]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[27]  Allen Taflove,et al.  Quantification of nanoscale density fluctuations using electron microscopy: Light-localization properties of biological cells. , 2010, Applied physics letters.

[28]  Vadim Backman,et al.  The influence of chromosome density variations on the increase in nuclear disorder strength in carcinogenesis , 2011, Physical biology.

[29]  P. Quirke,et al.  Experimental models of colorectal cancer , 1998, Diseases of the colon and rectum.

[30]  Vadim Backman,et al.  Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening. , 2011, Gastroenterology.

[31]  D. Fang,et al.  Mutation analysis of APC gene in gastric cancer with microsatellite instability. , 2002, World journal of gastroenterology.

[32]  Ping Zhu,et al.  The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 , 2003, The EMBO journal.

[33]  Lucia Altucci,et al.  Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.

[34]  W. Bickmore,et al.  The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? , 2005, EMBO reports.

[35]  P. Lichter,et al.  Histone acetylation increases chromatin accessibility , 2005, Journal of Cell Science.

[36]  V. Backman,et al.  Increased microvascular blood content is an early event in colon carcinogenesis , 2005, Gut.

[37]  Dian-chunFang,et al.  Mutation analysis of APC gene in gastric cancer with microsatellite instability , 2002 .

[38]  R. Kuiper,et al.  The epigenetics of (hereditary) colorectal cancer. , 2010, Cancer genetics and cytogenetics.

[39]  V. Backman,et al.  Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. , 2009, Optics letters.

[40]  Harry T Orr,et al.  Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.

[41]  H. Kawai,et al.  Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor α , 2003, International journal of cancer.

[42]  Y. Oda,et al.  Expression profile of class I histone deacetylases in human cancer tissues. , 2007, Oncology reports.

[43]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[44]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[45]  C. Van Lint,et al.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. , 1996, Gene expression.

[46]  Gary L Rosner,et al.  Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.

[47]  Ping Zhu,et al.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.

[48]  P. Marks,et al.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.

[49]  Vadim Backman,et al.  Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. , 2010, Cancer research.

[50]  D. Spiegelman,et al.  A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. , 2009, Gastroenterology.